Rohit Dutt

971 total citations
80 papers, 602 citations indexed

About

Rohit Dutt is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Rohit Dutt has authored 80 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmaceutical Science, 16 papers in Molecular Biology and 13 papers in Biomaterials. Recurrent topics in Rohit Dutt's work include Advanced Drug Delivery Systems (14 papers), Computational Drug Discovery Methods (11 papers) and Nanoparticle-Based Drug Delivery (11 papers). Rohit Dutt is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Computational Drug Discovery Methods (11 papers) and Nanoparticle-Based Drug Delivery (11 papers). Rohit Dutt collaborates with scholars based in India, Saudi Arabia and Bangladesh. Rohit Dutt's co-authors include Vandana Garg, Vikas Jhawat, Anil Kumar Madan, Rahul Pratap Singh, Sonali, А. К. Мадан, Md. Habibur Rahman, Abhishesh Kumar Mehata, Vineet Mittal and Madaswamy S. Muthu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and Molecules.

In The Last Decade

Rohit Dutt

74 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rohit Dutt India 13 180 124 117 93 72 80 602
Ritu Karwasra India 14 175 1.0× 102 0.8× 127 1.1× 85 0.9× 59 0.8× 43 567
Tarun Virmani India 16 158 0.9× 96 0.8× 116 1.0× 64 0.7× 86 1.2× 54 619
Fakhria A. Al‐Joufi Saudi Arabia 14 152 0.8× 104 0.8× 95 0.8× 60 0.6× 64 0.9× 94 669
Meeta Gera India 13 206 1.1× 93 0.8× 130 1.1× 56 0.6× 54 0.8× 20 699
Joana R. Campos Portugal 11 161 0.9× 147 1.2× 175 1.5× 104 1.1× 74 1.0× 19 691
Т. Г. Толстикова Russia 12 194 1.1× 74 0.6× 106 0.9× 74 0.8× 95 1.3× 66 622
Hamzah Maswadeh Saudi Arabia 14 129 0.7× 113 0.9× 97 0.8× 64 0.7× 37 0.5× 35 450
Cong Yan China 6 186 1.0× 104 0.8× 74 0.6× 91 1.0× 46 0.6× 11 584
Karolina Jafernik Poland 9 202 1.1× 119 1.0× 75 0.6× 54 0.6× 111 1.5× 17 511
Pahweenvaj Ratnatilaka Na Bhuket Thailand 14 184 1.0× 230 1.9× 183 1.6× 84 0.9× 45 0.6× 21 691

Countries citing papers authored by Rohit Dutt

Since Specialization
Citations

This map shows the geographic impact of Rohit Dutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rohit Dutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rohit Dutt more than expected).

Fields of papers citing papers by Rohit Dutt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rohit Dutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rohit Dutt. The network helps show where Rohit Dutt may publish in the future.

Co-authorship network of co-authors of Rohit Dutt

This figure shows the co-authorship network connecting the top 25 collaborators of Rohit Dutt. A scholar is included among the top collaborators of Rohit Dutt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rohit Dutt. Rohit Dutt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deepshikha, Deepshikha, M. Lamba, Vikas Jhawat, et al.. (2025). An Overview of Hypertension: Pathophysiology, Risk Factors, and Modern Management. Current Hypertension Reviews. 21(2). 64–81. 2 indexed citations
3.
Sonali, Vandana Garg, Rohit Dutt, et al.. (2024). AS1411 aptamer/RGD dual functionalized theranostic chitosan-PLGA nanoparticles for brain cancer treatment and imaging. Biomaterials Advances. 160. 213833–213833. 16 indexed citations
4.
Sharma, Prerna, et al.. (2024). Exploring the Therapeutic Potential of Phytoconstituents for AddressingNeurodegenerative Disorders. Central Nervous System Agents in Medicinal Chemistry. 24(2). 129–144. 3 indexed citations
5.
Maddiboyina, Balaji, et al.. (2023). Physiological Pathway, diagnosis and nanotechnology based treatment strategies for ovarian Cancer: A review. 8. 100020–100020. 9 indexed citations
6.
Rani, Anjali, et al.. (2023). Evaluation of Antioxidant, antibacterial and anticancer activity of fruit and leaf extracts of Manilkara zapota against A431 skin cancer cell lines. South African Journal of Botany. 153. 219–226. 5 indexed citations
7.
Verma, Ravinder, et al.. (2023). Green Synthesis, Characterization, and Biomedical Applications ofCopper and Copper Oxide Nanoparticles of Plant Origin. Current Drug Therapy. 18(5). 391–406. 9 indexed citations
8.
Singh, Rahul Pratap, Sonali, Abhishesh Kumar Mehata, et al.. (2023). Development and characterization of micelles for nucleolin-targeted co-delivery of docetaxel and upconversion nanoparticles for theranostic applications in brain cancer therapy. Journal of Drug Delivery Science and Technology. 87. 104808–104808. 15 indexed citations
9.
Mehata, Abhishesh Kumar, Amit Kumar Nayak, Rohit Dutt, et al.. (2023). RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy. International Journal of Pharmaceutics. 633. 122587–122587. 48 indexed citations
10.
Dutt, Rohit, Rahul Pratap Singh, Tarun Virmani, et al.. (2023). Amomum subulatum Fruit Extract Mediated Green Synthesis of Silver and Copper Oxide Nanoparticles: Synthesis, Characterization, Antibacterial and Anticancer Activities. Processes. 11(9). 2698–2698. 16 indexed citations
11.
Joshi, Shrikant, et al.. (2023). Isolation, characterization, and evaluation of anxiolytic bioactive compounds from the seed of Vigna radiata (L.) R. Wilczek in mice. Natural Product Research. 38(4). 706–709. 1 indexed citations
12.
Dutt, Rohit, Deepak Kaushik, Shashank Singh, et al.. (2022). Development of Biocompatible Nanoparticles of Tizanidine Hydrochloride in Orodispersible Films: In vitro Characterization, Ex vivo Permeation, and Cytotoxic Study on Carcinoma Cells. Current Drug Delivery. 19(10). 1061–1072. 7 indexed citations
13.
Purohit, Deepika, Ravinder Verma, Deepak Kaushik, et al.. (2022). Nanocapsules: An Emerging Drug Delivery System. Recent Patents on Nanotechnology. 17(3). 190–207. 19 indexed citations
14.
Jhawat, Vikas, et al.. (2022). Innovation in cancer therapeutics and regulatory perspectives. Medical Oncology. 39(5). 76–76. 48 indexed citations
15.
Sanduja, Mohit, et al.. (2022). Advancement of nanomedicines in chronic inflammatory disorders. Inflammopharmacology. 30(2). 355–368. 30 indexed citations
16.
Nanda, Arun, Esra Küpeli Akkol, Eduardo Sobarzo‐Sánchez, et al.. (2021). Ageratum conyzoides L. and Its Secondary Metabolites in the Management of Different Fungal Pathogens. Molecules. 26(10). 2933–2933. 45 indexed citations
17.
Mahor, Alok, Gyanendra Singh, Kuldeep K. Bansal, et al.. (2021). Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges. Journal of Pharmaceutical Sciences. 110(11). 3702–3714. 49 indexed citations
18.
Guarve, Kumar, et al.. (2020). Novel Coronavirus 2019 Outbreak: A Global Epidemic. Letters in Drug Design & Discovery. 17(12). 1458–1464. 4 indexed citations
19.
Dutt, Rohit, et al.. (2016). Interplay of “rest,” “internet,” and “diet” and on academic performancemedical students' perspective. National Journal of Physiology Pharmacy and Pharmacology. 6(6). 586–586. 1 indexed citations
20.
Garg, Vandana, et al.. (2012). Antianxiety Activity of Methanol Extract of Gelsemium sempervirens (Linn.)Ait.. Journal of stress physiology & biochemistry. 8(2). 118–124. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026